Biomarkers and biosensors for the early diagnosis of lung cancer

Sensors and Actuators, B: Chemical

Volumn 188, Issue , 2013, Pages 988-998

  Altintas, Zeynep ^a   Tothill, Ibtisam ^a  

^a CRANFIELD UNIVERSITY   (United Kingdom)

Author keywords

Biomarkers; Biosensor technology; Early diagnosis; Lung cancer; Non invasive detection

Indexed keywords

CURRENT DIAGNOSTICS; DIAGNOSTICS TOOLS; DISEASE BIOMARKER; EARLY DIAGNOSIS; LUNG CANCER; LUNG CANCER DETECTIONS; NON-INVASIVE DETECTION; RAPID DETECTION;

BIOLOGICAL ORGANS; BIOMARKERS; BIOSENSORS; COMPUTERIZED TOMOGRAPHY; CYTOLOGY; DISEASES; MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY;

DIAGNOSIS;

EID: 84883343355     PISSN: 09254005     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.snb.2013.07.078     Document Type: Review

References (129)

1. J. Ferlay, H. Shin, F. Bray, D. Forman, C. Mathers, and D. Parkin GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 2010
2. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA: A Cancer Journal for Clinicians 61 2011 69 90
3. M. van der Vaart, and P.J. Pretorius Is the role of circulating DNA as a biomarker of cancer being prematurely overrated? Clinical Biochemistry 43 2010 26 36
4. M. Paci, S. Maramotti, E. Bellesia, D. Formisano, L. Albertazzi, T. Ricchetti, G. Ferrari, V. Annessi, D. Lasagni, and C. Carbonelli Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer Lung Cancer 64 2009 92 97
5. K. Matsuoka, S. Sumitomo, N. Nakashima, D. Nakajima, and N. Misaki Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer European Journal of Cardio-thoracic Surgery 32 2007 435 439 (Pubitemid 47223713)
6. F. Alataş, Ö. Alataş, M. Metintaş, Ö. Çolak, E. Harmanci, and S. Demir Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions Lung Cancer 31 2001 9 16 (Pubitemid 32012598)
7. Y. Sakao, S. Tomimitsu, Y. Takeda, M. Natsuaki, and T. Itoh Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma European Journal of Cardio-thoracic Surgery 25 2004 520 522 (Pubitemid 38376063)
8. N. Sawabata, M. Ohta, S. Takeda, H. Hirano, Y. Okumura, H. Asada, and H. Maeda Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer Annals of Thoracic Surgery 74 2002 174
9. M.D. Seemann, T. Beinert, H. Fürst, and U. Fink An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions Lung Cancer 26 1999 149 155 (Pubitemid 30114217)
10. F. Barlési, C. Gimenez, J.P. Torre, C. Doddoli, J. Mancini, L. Greillier, F. Roux, and J.P. Kleisbauer Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer Respiratory Medicine 98 2004 357 362 (Pubitemid 38443696)
11. R. Molina, J.M. Auge, J.M. Escudero, R. Marrades, N. Viñolas, E. Carcereny, J. Ramirez, and X. Filella Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE Tumour Biology 29 2008 371
12. Z. Altintas, S.S. Kallempudi, U. Sezerman, and Y. Gurbuz A novel magnetic particle-modified electrochemical sensor for immunosensor applications Sensors and Actuators B: Chemical 174 2012 187 194
13. Z. Altintas, Y. Uludag, Y. Gurbuz, and I.E. Tothill Surface plasmon resonance based immunosensor for the detection of the cancer biomarker carcinoembriyonic antigen Talanta 86 2011 377 383
14. F. Su, C. Xu, M. Taya, K. Murayama, Y. Shinohara, and S.I. Nishimura Detection of carcinoembryonic antigens using a surface plasmon resonance biosensor Sensors 8 2008 4282 4295
15. P. Iyengar, and M.S. Tsao Clinical relevance of molecular markers in lung cancer Surgical Oncology 11 2002 167 179 (Pubitemid 35356566)
16. S. Ando, H. Kimura, N. Iwai, Y. Nomoto, M. Shima, M. Ando, and T. Kuriyama Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer Anticancer Research 21 2001 3085 3092 (Pubitemid 33051180)
17. S. Mizuguchi, N. Nishiyama, T. Iwata, T. Nishida, N. Izumi, T. Tsukioka, K. Inoue, T. Uenishi, K. Wakasa, and S. Suehiro Serum Sialyl Lewisx and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer Lung Cancer 58 2007 369 375 (Pubitemid 350051511)
18. D. Shitrit, B. Zingerman, A.B.G. Shitrit, D. Shlomi, and M.R. Kramer Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature The Oncologist 10 2005 501 507 (Pubitemid 41266331)
19. L. Drivsholm, L. Paloheimo, and K. ∅sterlind Chromogranin A, a significant prognostic factor in small cell lung cancer British Journal of Cancer 81 1999 667 671 (Pubitemid 29458863)
20. V. Gregorc, A. Spreafico, I. Floriani, B. Colombo, V. Ludovini, L. Pistola, G. Bellezza, M.G. Viganò, E. Villa, and A. Corti Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer Cancer 110 2007 845 853 (Pubitemid 47257663)
21. P.J. Lamy, J. Grenier, A. Kramar, and J.L. Pujol Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer Lung Cancer 29 2000 197 203
22. S. Holdenrieder, and P. Stieber Apoptotic markers in cancer Clinical Biochemistry 37 2004 605 617 (Pubitemid 38845023)
23. X. Wu, C.I. Amos, Y. Zhu, H. Zhao, B.H. Grossman, J.W. Shay, S. Luo, W.K. Hong, and M.R. Spitz Telomere dysfunction: a potential cancer predisposition factor Journal of the National Cancer Institute 95 2003 1211 1218 (Pubitemid 37069551)
24. Q. An, Y. Liu, Y. Gao, J. Huang, X. Fong, L. Li, D. Zhang, and S. Cheng Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients Cancer Letters 188 2002 109 114 (Pubitemid 35292336)
25. A. Comandini, P. Rogliani, A. Nunziata, M. Cazzola, G. Curradi, and C. Saltini Biomarkers of lung damage associated with tobacco smoke in induced sputum Respiratory Medicine 103 2009 1592 1613
26. Y. Xie, N.W. Todd, Z. Liu, M. Zhan, H.B. Fang, H. Peng, M. Alattar, J. Deepak, S.A. Stass, and F. Jiang Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer Lung Cancer 67 2010 170 176
27. P. Mandel, and P. Metais Nucleic acids of human blood plasma Comptes Rendus des Seances de la Societe de Biologie et des ses Filiales (Paris) 142 1948 241 243
28. G. Sozzi, D. Conte, L. Mariani, S. Lo Vullo, L. Roz, C. Lombardo, M.A. Pierotti, and L. Tavecchio Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients Cancer Research 61 2001 4675 4678 (Pubitemid 32691874)
29. G. Sozzi, D. Conte, M.E. Leon, R. Cirincione, L. Roz, C. Ratcliffe, E. Roz, N. Cirenei, M. Bellomi, and G. Pelosi Quantification of free circulating DNA as a diagnostic marker in lung cancer Journal of Clinical Oncology 21 2003 3902 3908 (Pubitemid 46606202)
30. Y.L. Cheng, S.C. Lee, H.J. Harn, C.J. Chen, Y.C. Chang, J.C. Chen, and C.P. Yu Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer European Journal of Cardio-thoracic Surgery 23 2003 221 228
31. F. Grossi, M. Loprevite, M. Chiaramondia, P. Ceppa, C. Pera, G. Ratto, J. Serrano, G. Ferrara, R. Costa, and L. Boni Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers European Journal of Cancer 39 2003 1242 1250 (Pubitemid 36579195)
32. T. Mitsudomi, N. Hamajima, M. Ogawa, and T. Takahashi Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis Clinical Cancer Research 6 2000 4055 4063
33. T. Oyama, T. Osaki, N. Nose, Y. Ichiki, M. Inoue, H. Imoto, T. Yoshimatsu, M. Kodate, H. Uramoto, and T. Mizoue Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma Anticancer Research 20 2000 505 510 (Pubitemid 30189710)
34. S.A. Belinsky, D.M. Klinge, K.C. Liechty, T.H. March, T. Kang, F.D. Gilliland, N. Sotnic, G. Adamova, G. Rusinova, and V. Telnov Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma Carcinogenesis 25 2004 1063 1067 (Pubitemid 38886088)
35. D.H. Kim, H.H. Nelson, J.K. Wiencke, S. Zheng, D.C. Christiani, J.C. Wain, E.J. Mark, and K.T. Kelsey p16INK4a and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer Cancer Research 61 2001 3419 3424 (Pubitemid 32695035)
36. K. Kondo, Y. Takahashi, Y. Hirose, T. Nagao, M. Tsuyuguchi, M. Hashimoto, A. Ochiai, Y. Monden, and A. Tangoku The reduced expression and aberrant methylation of p16INK4a in chromate workers with lung cancer Lung Cancer 53 2006 295 302 (Pubitemid 44192596)
37. G.M. Cooper Cellular transforming genes Science 217 1982 801 806 (Pubitemid 12042904)
38. J. Downward Targeting RAS signalling pathways in cancer therapy Nature Reviews Cancer 3 2003 11 22 (Pubitemid 37328883)
39. O. Gautschi, B. Huegli, A. Ziegler, M. Gugger, J. Heighway, D. Ratschiller, P. Mack, P. Gumerlock, H. Kung, and R. Stahel Origin and prognostic value of circulating KRAS mutations in lung cancer patients Cancer Letters 254 2007 265 273 (Pubitemid 47126691)
40. O. Kovalchuk, W. Naumnik, A. Serwicka, E. Chyczewska, J. Niklinski, and L. Chyczewski K-ras codon 12 mutations may be detected in serum of patients suffering from adeno-and large cell lung carcinoma. A preliminary report, Folia histochemica et cytobiologica/Polish Academy of Sciences Polish Histochemical and Cytochemical Society 39 2001 70
41. L. Mao, R.H. Hruban, J.O. Boyle, M. Tockman, and D. Sidransky Detection of oncogene mutations in sputum precedes diagnosis of lung cancer Cancer Research 54 1994 1634
42. H.D. Hosgood, R. Cawthon, X. He, S. Chanock, and Q. Lan Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility Lung Cancer 66 2009 157 161
43. J.S. Jang, Y.Y. Choi, W.K. Lee, J.E. Choi, S.I. Cha, Y.J. Kim, C.H. Kim, S. Kam, T.H. Jung, and J.Y. Park Telomere length and the risk of lung cancer Cancer Science 99 2008 1385 1389 (Pubitemid 351761728)
44. S. Aviel-Ronen, B.P. Coe, S.K. Lau, G. da Cunha Santos, C.Q. Zhu, D. Strumpf, I. Jurisica, W.L. Lam, and M.S. Tsao Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features Proceedings of the National Academy of Sciences 105 2008 10155 10160
45. J.U. Kang, S.H. Koo, K.C. Kwon, J.W. Park, and J.M. Kim Gain at chromosomal region 5p15. 33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer Cancer Genetics and Cytogenetics 182 2008 1 11 (Pubitemid 351323956)
46. S. Leon, B. Shapiro, D. Sklaroff, and M. Yaros Free DNA in the serum of cancer patients and the effect of therapy Cancer Research 37 1977 646 650 (Pubitemid 8051621)
47. B. Shapiro, M. Chakrabarty, E.M. Cohn, and S.A. Leon Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease Cancer 51 1983 2116 2120 (Pubitemid 13092467)
48. M. Stroun, P. Anker, P. Maurice, J. Lyautey, C. Lederrey, and M. Beljanski Neoplastic characteristics of the DNA found in the plasma of cancer patients Oncology 46 1989 318 322 (Pubitemid 19216753)
49. G.D. Sorenson, D.M. Pribish, F.H. Valone, V.A. Memoli, D.J. Bzik, and S.L. Yao Soluble normal and mutated DNA sequences from single-copy genes in human blood Cancer Epidemiology Biomarkers & Prevention 3 1994 67 71
50. V. Vasioukhin, P. Anker, P. Maurice, J. Lyautey, C. Lederrey, and M. Stroun Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia British Journal of Haematology 86 1994 774 779 (Pubitemid 24194434)
51. G.P. Pfeifer, and T.A. Rauch DNA methylation patterns in lung carcinomas Seminars in Cancer Biology 19 2009 181 187
52. D.A. Tsao, M.J. Yang, H.J. Chang, L.C. Yen, H.H. Chiu, E.J. Hsueh, Y.F. Chen, and S.R. Lin A fast and convenient new technique to detect the therapeutic target, K-ras mutant, from peripheral blood in non-small cell lung cancer patients Lung Cancer 68 2010 51 57
53. C.J.B. Brimelow E. Kress-Rogers, C.J.B. Brimelow, Instrumentation and Sensors for the Food Industry 2001 Woodhead Publishing
54. F.J. Mulaa, and P.M. Krämer 13 Biosensors D.W. Sun, Handbook of Food Safety Engineering 2011 Wiley Blackwill 313
55. I.E. Tothill Biosensors for cancer markers diagnosis Seminars in Cell and Developmental Biology 20 2009 55 62
56. J. Homola Present and future of surface plasmon resonance biosensors Analytical and Bioanalytical Chemistry 377 2003 528 539 (Pubitemid 40882962)
57. J. Ladd, A.D. Taylor, M. Piliarik, J. Homola, and S. Jiang Label-free detection of cancer biomarker candidates using surface plasmon resonance imaging Analytical and Bioanalytical Chemistry 393 2009 1157 1163
58. H. Vaisocherová, V.M. Faca, A.D. Taylor, S. Hanash, and S. Jiang Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera Biosensors and Bioelectronics 24 2009 2143 2148
59. 2 for cancer biomarker detection V.R. Preedy, V.B. Petel, Biosensors and Cancer 2012 CRC Press 20 43
60. N.D. Brault, S. Jiang, and Q. Yu Dual-functional zwitterionic carboxybetaine for highly sensitive and specific cancer biomarker detection in complex media using SPR biosensors K.E. Herold, A. Rasooly, Biosensors for Cancer Diagnostics 2012 CRC press 69 88
61. B. Sciacca, A. François, P. Hoffmann, and T.M. Monro Multiplexing of radiative-surface plasmon resonance for the detection of gastric cancer biomarkers in a single optical fiber Sensors and Actuators B: Chemical 183 2013 454 458
62. Y. Shin, A.P. Perera, and M.K. Park Label-free DNA sensor for detection of bladder cancer biomarkers in urine Sensors and Actuators B: Chemical 178 2013 200 206
63. M. Perfézou, A. Turner, and A. Merkoçi Cancer detection using nanoparticle-based sensors Chemical Society Reviews 41 2012 2606 2622
64. C. Escobedo, Y.-W. Chou, M. Rahman, X. Duan, R. Gordon, D. Sinton, A.G. Brolo, and J. Ferreira Quantification of ovarian cancer markers with integrated microfluidic concentration gradient and imaging nanohole surface plasmon resonance Analyst 138 2013 1450 1458
65. T. Springer, M. Bockova, and J. Homola Towards label-free biosensing in complex media: a novel referencing approach Analytical Chemistry 85 2013 5637 5640
66. C. Liu, T. Lei, K. Ino, T. Matsue, N. Tao, and C.-Z. Li Real-time monitoring biomarker expression of carcinoma cells by surface plasmon resonance biosensors Chemical Communications 48 2012 10389 10391
67. S. Tombelli, and M. Mascini Biosensors for clinical biomarkers Predictive Approaches in Drug Discovery and Development: Biomarkers and In Vitro/In Vivo Correlations vol. 11 2012 203 224
68. Y. Li, H.J. Lee, and R.M. Corn Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging Analytical Chemistry 79 2007 1082 1088
69. J. Ladd, H. Lu, A.D. Taylor, V. Goodell, M.L. Disis, and S. Jiang Direct detection of carcinoembryonic antigen autoantibodies in clinical human serum samples using a surface plasmon resonance sensor Colloids and Surfaces B: Biointerfaces 70 2009 1 6
70. Z. Altintas, and I.E. Tothill DNA-based biosensor platforms for the detection of TP53 mutation Sensors and Actuators B: Chemical 169 2012 188 194
71. Z. Altintas, Y. Uludag, Y. Gurbuz, and I. Tothill Development of surface chemistry for SPR based sensors for the detection of proteins and DNA molecules Analytica Chimica Acta 86 2011 377 383
72. A. Laschitsch, and D. Johannsmann High frequency tribological investigations on quartz resonator surfaces Journal of Applied Physics 85 1999 3759 3765 (Pubitemid 129618158)
73. M.A. Cooper, and V.T. Singleton A survey of the 2001 to 2005 quartz crystal microbalance biosensor literature: applications of acoustic physics to the analysis of biomolecular interactions Journal of Molecular Recognition 20 2007 154 184 (Pubitemid 47075114)
74. S. Carrara, V. Bhalla, C. Stagni, L. Benini, A. Ferretti, F. Valle, A. Gallotta, B. Riccň, and B. Samorě Label-free cancer markers detection by capacitance biochip Sensors and Actuators B: Chemical 136 2009 163 172
75. J.-A.A. Ho, H.-C. Chang, N.-Y. Shih, L.-C. Wu, Y.-F. Chang, C.-C. Chen, and C. Chou Diagnostic detection of human lung cancer-associated antigen using a gold nanoparticle-based electrochemical immunosensor Analytical Chemistry 82 2010 5944 5950
76. R. Malhotra, V. Patel, J.P. Vaqué, J.S. Gutkind, and J.F. Rusling Ultrasensitive electrochemical immunosensor for oral cancer biomarker IL-6 using carbon nanotube forest electrodes and multilabel amplification Analytical Chemistry 82 2010 3118 3123
77. F. Wei, P. Patel, W. Liao, K. Chaudhry, L. Zhang, M. Arellano-Garcia, S. Hu, D. Elashoff, H. Zhou, and S. Shukla Electrochemical sensor for multiplex biomarkers detection Clinical Cancer Research 15 2009 4446 4452
78. J.F. Rusling, B. Munge, N.P. Sardesai, R. Malhotra, and B.V. Chikkaveeraiah Nanoscience-based electrochemical sensors and arrays for detection of cancer biomarker proteins F.N. Crespilho, Nanobioelectrochemistry 2013 Springer 1 26
79. R. Malhotra, V. Patel, B.V. Chikkaveeraiah, B.S. Munge, S.C. Cheong, R.B. Zain, M.T. Abraham, D.K. Dey, J.S. Gutkind, and J.F. Rusling Ultrasensitive detection of cancer biomarkers in the clinic by use of a nanostructured microfluidic array Analytical Chemistry 84 2012 6249 6255
80. D. Du, J. Wang, L. Wang, D. Lu, and Y. Lin Integrated lateral flow test strip with electrochemical sensor for quantification of phosphorylated cholinesterase: biomarker of exposure to organophosphorus agents Analytical Chemistry 84 2012 1380 1385
81. B.V. Chikkaveeraiah, A.A. Bhirde, N.Y. Morgan, H.S. Eden, and X. Chen Electrochemical immunosensors for detection of cancer protein biomarkers ACS Nano 6 2012 6546 6561
82. H. Li, J. He, S. Li, and A.P. Turner Electrochemical immunosensor with N-doped graphene-modified electrode for label-free detection of the breast cancer biomarker CA 15-3 Biosensors and Bioelectronics 43 2012 25 29
83. N.P. Sardesai, K. Kadimisetty, R. Faria, and J.F. Rusling A microfluidic electrochemiluminescent device for detecting cancer biomarker proteins Analytical and Bioanalytical Chemistry 405 2013 3831 3838
84. S. Viswanathan, C. Rani, S. Ribeiro, and C. Delerue-Matos Molecular imprinted nanoelectrodes for ultra sensitive detection of ovarian cancer marker Biosensors and Bioelectronics 33 2012 179 183
85. J.F. Rusling Multiplexed electrochemical protein detection and translation to personalized cancer diagnostics Analytical Chemistry 85 2013 5304 5310
86. R. Akter, M.A. Rahman, and C.K. Rhee Amplified electrochemical detection of a cancer biomarker by enhanced precipitation using horseradish peroxidase attached on carbon nanotubes Analytical Chemistry 84 2012 6407 6415
87. T. Yang, S. Wang, H. Jin, W. Bao, S. Huang, and J. Wang An electrochemical impedance sensor for the label-free ultrasensitive detection of interleukin-6 antigen Sensors and Actuators B: Chemical 178 2013 310 315
88. J. Li, S. Li, and C.F. Yang Electrochemical biosensors for cancer biomarker detection Electroanalysis 24 2012 2213 2229
89. A. Chen, and S. Chatterjee Nanomaterials based electrochemical sensors for biomedical applications Chemical Society Reviews 42 2013 5425 5438
90. J.F. Rusling Nanomaterials-based electrochemical immunosensors for proteins The Chemical Record 12 2012 164 176
91. Y. Li, Z. Zhong, Y. Chai, Z. Song, Y. Zhuo, H. Su, S. Liu, D. Wang, and R. Yuan Simultaneous electrochemical immunoassay of three liver cancer biomarkers using distinguishable redox probes as signal tags and gold nanoparticles coated carbon nanotubes as signal enhancers Chemical Communications 48 2012 537 539
92. X. Chen, X. Jia, J. Han, J. Ma, and Z. Ma Electrochemical immunosensor for simultaneous detection of multiplex cancer biomarkers based on graphene nanocomposites Biosensors and Bioelectronics 50 2013 356 361
93. C. Berggren, B. Bjarnason, and G. Johansson Capacitive biosensors Electroanalysis 13 2001 173 180 (Pubitemid 32244678)
94. S.S. Kallempudi, Z. Altintas, J.H. Niazi, and Y. Gurbuz A new microfluidics system with a hand-operated, on-chip actuator for immunosensor applications Sensors and Actuators B: Chemical 163 2012 194 201
95. J.D. Boice Jr., D. Preston, F.G. Davis, and R.R. Monson Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts Radiation Research 125 1991 214 222
96. A.B. de González, and S. Darby Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries Lancet 363 2004 345 351 (Pubitemid 38169539)
97. I. Watt, I. Stewart, D. Anderson, G. Bell, and J. Anderson Laparoscopy, ultrasound and computed tomography in cancer of the oesophagus and gastric cardia: a prospective comparison for detecting intra-abdominal metastases British Journal of Surgery 76 1989 1036 1039 (Pubitemid 19251498)
98. D. Lardinois, W. Weder, T.F. Hany, E.M. Kamel, S. Korom, B. Seifert, G.K. von Schulthess, and H.C. Steinert Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography New England Journal of Medicine 348 2003 2500 2507 (Pubitemid 36706537)
99. M.O. Leach, C. Boggis, A. Dixon, D. Easton, R. Eeles, D. Evans, F. Gilbert, I. Griebsch, R. Hoff, and P. Kessar Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) Lancet 365 2005 1769 1778 (Pubitemid 40744657)
100. R. Beets-Tan, G. Beets, R. Vliegen, A. Kessels, H.V. Boven, A.D. Bruine, M. Von Meyenfeldt, C. Baeten, and J. Van Engelshoven Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery Lancet 357 2001 497 504 (Pubitemid 32173585)
101. J.M. Ollinger, and J.A. Fessler Positron-emission tomography IEEE Signal Processing Magazine 14 1997 43 55 (Pubitemid 127548898)
102. M.M. Ter-Pogossian, M.E. Raichle, and B.E. Sobel Positron-emission tomography Scientific American 243 1980 170 175
103. W.A. Palmisano, K.K. Divine, G. Saccomanno, F.D. Gilliland, S.B. Baylin, J.G. Herman, and S.A. Belinsky Predicting lung cancer by detecting aberrant promoter methylation in sputum Cancer Research 60 2000 5954 5958
104. L.B. Woolner, and J.R. McDonald Biopsy in cancer diagnosis Plastic and Reconstructive Surgery 9 1952 388 390
105. J.D. Kronz, C.H. Allan, A.A. Shaikh, and J.I. Epstein Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy The American Journal of Surgical Pathology 25 2001 1079 1085 (Pubitemid 32685907)
106. A. Gajra, A.H. Tatum, N. Newman, G.P. Gamble, S. Lichtenstein, M.T. Rooney, and S.L. Graziano The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer Lung Cancer 36 2002 159 165 (Pubitemid 34302892)
107. J. Zhou, L. Nong, M. Wloch, A. Cantor, J.L. Mulshine, and M.S. Tockman Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer Lung Cancer 34 2001 341 350 (Pubitemid 33048796)
108. G. Kristiansen, Y. Yu, S. Petersen, O. Kaufmann, K. Schluns, M. Dietel, and I. Petersen Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer European Journal of Cancer 37 2001 1089 1095
109. M. Woenckhaus, J. Merk, R. Stoehr, F. Schaeper, A. Gaumann, K. Wiebe, A. Hartmann, F. Hofstaedter, and W. Dietmaier Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer Human Pathology 39 2008 126 136 (Pubitemid 350216169)
110. F. Andriani, D. Conte, T. Mastrangelo, M.E. Leon, C. Ratcliffe, L. Roz, G. Pelosi, P. Goldstraw, G. Sozzi, and U. Pastorino Detecting lung cancer in plasma with the use of multiple genetic markers International Journal of Cancer 108 2004 91 96 (Pubitemid 37444449)
111. E. Carcereny, J.L. Ramirez, M. Sanchez-Ronco, D. Isla, M. Cobo, T. Moran, I. de Aguirre, T. Okamoto, J. Wei, and M. Provencio Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients Lung Cancer 68 2010 491 497
112. M. Romanowska, A. Maciag, A.L. Smith, J.R. Fields, L.W. Fornwald, K.D. Kikawa, K.S. Kasprzak, and L.M. Anderson DNA damage, superoxide, and mutant K-ras in human lung adenocarcinoma cells Free Radical Biology and Medicine 43 2007 1145 1155 (Pubitemid 47381414)
113. C. Camps, R. Sirera, R. Bremnes, A. Blasco, E. Sancho, P. Bayo, M.J. Safont, J.J. Sánchez, M. Tarón, and R. Rosell Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer? Lung Cancer 50 2005 339 346
114. S.A. Belinsky, K.J. Nikula, W.A. Palmisano, R. Michels, G. Saccomanno, E. Gabrielson, S.B. Baylin, and J.G. Herman Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis Proceedings of the National Academy of Sciences 95 1998 11891 11896
115. H. Sasaki, H. Yukiue, Y. Kobayashi, M. Tanahashi, S. Moriyama, Y. Nakashima, I. Fukai, M. Kiriyama, Y. Yamakawa, and Y. Fujii Expression of the cdc25B gene as a prognosis marker in non-small cell lung cancer Cancer Letters 173 2001 187 192 (Pubitemid 32971937)
116. M. Spinola, V.P. Leoni, A. Galvan, E. Korsching, B. Conti, U. Pastorino, F. Ravagnani, A. Columbano, V. Skaug, and A. Haugen Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene Cancer Letters 251 2007 311 316 (Pubitemid 46669803)
117. W.K. Lee, J.S. Kim, H.G. Kang, S.I. Cha, D.S. Kim, D.S. Hyun, S. Kam, C.H. Kim, T.H. Jung, and J.Y. Park Polymorphisms in the caspase 7 gene and the risk of lung cancer Lung Cancer 65 2009 19 24
118. J.S. Jang, K.M. Kim, K.H. Kang, J.E. Choi, W.K. Lee, C.H. Kim, Y.M. Kang, S. Kam, I.S. Kim, and J.E. Jun Polymorphisms in the survivin gene and the risk of lung cancer Lung Cancer 60 2008 31 39 (Pubitemid 351434465)
119. C. Planque, M. de Monte, S. Guyetant, J. Rollin, C. Desmazes, V. Panel, E. Lemarié, and Y. Courty KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer Biochemical and Biophysical Research Communications 329 2005 1260 1266 (Pubitemid 40568705)
120. J. Feng, J. Wu, S. Hu, C. Gao, M. Shi, Z. Lu, X. Sun, J.R. Zhou, and B. Chen Polymorphisms of the ribonucleotide reductase M1 gene and sensitivity to platin-based chemotherapy in non-small cell lung cancer Lung Cancer 66 2009 344 349
121. N. Yanagawa, G. Tamura, H. Oizumi, N. Kanauchi, M. Endoh, M. Sadahiro, and T. Motoyama Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers Lung Cancer 58 2007 131 138 (Pubitemid 47379969)
122. P. Gresner, J. Gromadzinska, E. Jablonska, J. Kaczmarski, and W. Wasowicz Expression of selenoprotein-coding genes SEPP1, SEP15 and hGPX1 in non-small cell lung cancer Lung Cancer 65 2009 34 40
123. W.P. Carney Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers Expert Review of Molecular Diagnostics 7 2007 309 319 (Pubitemid 46798620)
124. Y. Kimura, T. Fujii, K. Hamamoto, N. Miyagawa, M. Kataoka, and A. Iio Serum CA125 level is a good prognostic indicator in lung cancer British Journal of Cancer 62 1990 676 678 (Pubitemid 20340590)
125. G. Manukyan, K. Ghazaryan, Z.A. Ktsoyan, M. Tatyan, Z. Khachatryan, G. Hakobyan, V. Mkrtchyan, D. Kelly, A. Coutts, and R. Aminov Cytokine profile of Armenian patients with Familial Mediterranean fever Clinical Biochemistry 41 2008 920 922
126. A. Ilyas, W. Asghar, P.B. Allen, H. Duhon, A.D. Ellington, and S.M. Iqbal Electrical detection of cancer biomarker using aptamers with nanogap break-junctions Nanotechnology 23 2012 1 8
127. Y. Sato, K. Fujimoto, and H. Kawaguchi Detection of a K-ras point mutation employing peptide nucleic acid at the surface of a SPR biosensor Colloids and Surfaces B: Biointerfaces 27 2003 23 31 (Pubitemid 35346318)
128. Y. Wang, X. Zhu, M. Wu, N. Xia, J. Wang, and F. Zhou Simultaneous and label-free determination of wild-type and mutant p53 at a single surface plasmon resonance chip preimmobilized with consensus DNA and monoclonal antibody Analytical Chemistry 81 2009 8441 8446
129. J. Chung, R. Bernhardt, and J. Pyun Additive assay of cancer marker CA 19-9 by SPR biosensor Sensors and Actuators B: Chemical 118 2006 28 32 (Pubitemid 44287386)